The WHO recommendations stimulate the adoption of these technologies, delivered they can be validated to show equivalent or outstanding general performance in comparison with conventional procedures. Manufacturers aiming to put into action these approaches should deliver sturdy validation facts to reveal their equivalence to pharmacopoeial s